Know your Pharmacy Benefit Management (PBM) Pharmacist

November 30, 2022

Pharmacists are medication experts that play a critical role in helping patients achieve optimal results from their medications.

Some of the tasks that pharmacists perform include preparing and dispensing prescriptions, ensuring medications and doses are correct, preventing potentially harmful drug interactions, and counseling patients on the safe and appropriate use of their medications, among other responsibilities. Also, pharmacists are considered the most accessible healthcare professionals.


Most people are familiar with the role of the community pharmacist. Community pharmacists provide services in an independent or chain retail pharmacy. They interpret, dispense, verify, and provide medication counseling regarding the appropriate and correct use of your medications. They also have an important role in vaccination efforts for influenza, pneumonia, COVID-19, and others.


In addition, pharmacists may have other roles in the healthcare industry within the different fields in which they may work.  These fields include: 

  • Hospital Pharmacy, inpatient and/or outpatient setting
  • Pharmaceutical Industry
  • Academia (i.e. school, college or university)
  • Research
  • Managed Care (Pharmacy Benefit Management (PBM), Managed Care Organization (MCO), Health Plans)
  • PBM: The intermediary between employers, MCOs, beneficiaries, drug wholesalers, pharmacies, and drug companies, working to optimize cost-effective strategies to achieve the best possible health outcomes.
  • MCO:  A managed care organization (MCO) is a healthcare provider or group of medical service providers who offer managed care health plans. It is an organization that contracts with insurers or self-insured employers, and finances and delivers healthcare using a specific provider network and specific services and products.
  • Health Plan:  An individual or group plan that provides or pays the cost of medical care.
  • Government (Food and Drug Administration (FDA), National Institute of Health (NIH), Military)
  • Specialty Pharmacy: Pharmacists who work in specialty disease states such as oncology, organ transplant, inflammatory conditions, or infectious disease, and are trained to be experts on complex drug therapy regimens that usually require close monitoring and follow-up with patients and providers.
  • Mail Order Pharmacy:  Pharmacists that work in a pharmacy setting in which prescription medications are sent to the patient by mail.


MC-Rx
is a Pharmacy Benefit Manager (PBM), a company that manages prescription drug benefits on behalf of health insurers, Medicare Part D drug plans, large employers, and other payers. PBMs are your advocates in the healthcare system working to ensure the appropriate, most effective, and safe medications are available to beneficiaries. A PBM optimizes the formulary (a list of prescription drugs covered by a health plan) according to scientific evidence and clinical guidelines. Optimal formulary design and management services offered by PBMs help achieve lower prescription drug costs for patients and payers. The PBM pharmacist focuses on managing medication-specific outcomes in a way that drives down total health utilization costs and improves patient care.


A PBM pharmacist works with clients (e.g. health plans, employers, MCOs) to evaluate and improve their pharmacy benefit. The responsibilities of a PBM pharmacist may include:

  • Formulary and Drug Utilization Management – Managing the list of medications covered by the health plan and monitor prescription drug trends.
  • Coordinating and participating in the Pharmacy and Therapeutics Committee (P&T) – The P&T committee is a multidisciplinary team that evaluates effectiveness and safety of medications in order to make evidence-based decisions for disease management. P&T committees are generally composed of the following disciplines: physicians with specialties in different areas of medicine and pharmacists.
  • Account Management – The responsibilities of an account manager include retaining client (e.g. employers, MCOs, health plan) business by identifying strategic growth opportunities based on the client’s formulary design. An example may be offering effective drug management tools (e.g. prior authorization criteria or quantity limits) to ensure cost-effective access to medications.
  • Prior Authorization Process – Pharmacists evaluate the prescriptions based on the diagnoses and supporting documentation sent by the pharmacy/physician to determine the appropriate use of the medication according to the patient/beneficiary pharmacy coverage.
  • PBM pharmacists ensure the pharmacy benefit plan provides individual patients with medications that are: clinically appropriate, cost effective, and delivered through the appropriate channel; for example, via specialty pharmacy, retail pharmacy, or mail order pharmacy.



MC-Rx PBM pharmacists are committed to serve beneficiaries by ensuring access to the best care and achieving optimization of their pharmacy benefit.


References:

https://www.commonwealthfund.org/publications/explainer/2019/apr/pharmacy-benefit-managers-and-their- role-drug-spending

https://www.mc-rx.com/




A stethoscope is laying on a piece of paper next to a pen
December 12, 2024
URAC accreditation reflects ProCare Rx’s commitment to achieving and maintaining the highest quality, member engagement and experience, and operational standards for PBMs in the industry
By Mc-Rx Team November 15, 2024
Mental health parity and medication adherence
By MC-Rx Clinical Team August 7, 2024
Understanding GLP-1 Medications The landscape of obesity management is evolving, with GLP-1 receptor agonist (RA) medications emerging as a significant player. These FDA-approved drugs have proven effective in helping individuals lose weight, prompting a shift in how they are viewed and covered by health plans. However, the cost implications and strategic decisions surrounding these medications require careful consideration by employer groups and their members. The Case for GLP-1 Medications GLP-1 RAs, originally developed for diabetes management, have shown remarkable efficacy in weight loss. With the growing prevalence of obesity and its associated healthcare costs, there's increasing pressure on health plans to cover these medications. Despite their high cost—annual retail pharmacy expenses can exceed $10,000 per patient—GLP-1 RAs offer potential downstream savings by reducing obesity-related comorbidities such as diabetes, hypertension, and cardiovascular disease​​. Balancing Coverage and Cost Historically, weight loss medications were deemed "lifestyle" drugs and excluded from coverage. However, the rising popularity of GLP-1 RAs and their demonstrated benefits are challenging this perspective. For plan sponsors, the decision to cover these medications involves balancing the high upfront costs with the potential for long-term savings on medical expenses related to obesity. Cost-Containment Strategies For payers choosing to cover GLP-1 medications, several cost-containment strategies can be employed: Formulary Management : Deciding on the placement of these medications within the formulary is crucial. Options range from not covering the drugs to placing them on a high-cost tier with patient cost-sharing. Prior Authorization and Step Therapy : Implementing these measures ensures that only patients with a proper diagnosis (e.g., ICD-10 code for obesity) access these medications, preventing misuse and overutilization. Prerequisite Programs : Requiring participation in wellness or nutrition programs before approving weight loss medications can encourage lifestyle modifications that complement pharmacological treatment. Specialist Restrictions : Limiting prescriptions to weight loss specialists, such as bariatric doctors or endocrinologists, ensures appropriate therapy and monitoring. Duration Limits : Establishing treatment guidelines, such as discontinuing medications if a target weight loss is not achieved within six months, helps manage long-term costs​​. The Role of Brokers and Employer Groups Brokers play a pivotal role in guiding employer groups through the complexities of covering GLP-1 medications. Understanding the cost-benefit dynamics and available cost-containment strategies enables brokers to provide informed recommendations that align with their clients' financial and health objectives. Employer groups, in turn, must weigh the potential benefits of covering these medications against their budgetary constraints and the overall well-being of their workforce. Member Education and Engagement Effective communication with members is essential to ensure they understand the coverage options and adhere to prescribed treatments. Educational initiatives can include: Patient Communication Programs : Providing information on medication adherence, compliance, and lifestyle modifications. Continuing Education : Ongoing programs to keep members informed about the benefits and proper use of weight loss medications. Monitoring and Support : Utilizing pharmacy and medical data to track outcomes and adjust strategies as needed​​. Balance the Scale with Expert Guidance from MC-Rx The adoption of GLP-1 medications for weight loss represents a significant advancement in obesity management. However, the high costs associated with these drugs necessitate careful planning and strategic implementation by brokers, employer groups, and members. By employing robust cost-containment strategies and prioritizing member education, health plans can navigate the financial challenges while delivering meaningful health benefits to their populations. MC-Rx, as a full-service pharmacy benefits manager, offers the expertise and tools to help clients optimize their coverage decisions and manage the complexities of incorporating GLP-1 medications into their health plans. Here are just a few of the GLP-1 strategies we use to shield our clients from excessive costs: Implementation of Drug Management Tools, which is critical to ensure proper utilization for GLP-1s. Strategic Benefit Design, which also protects clients from improper GLP-1 utilization. Clear Member Communication, which is crucial for proper adherence and compliance. When implemented with an existing client, the above-listed strategies helped them achieve $382,000 in cost avoidance for GLP-1s. With the right approach, the benefits of these medications can be realized, contributing to better health outcomes and potentially lowering overall healthcare costs in the long run. For more information on managing GLP-1 medications and other pharmacy benefits, reach out to an MC-Rx expert today .
By MC-Rx Clinical Team August 2, 2024
Mental Health Parity and Medication Adherence
March 21, 2024
MC-Rx, powered by ProCare Rx, has been notified by the Academy of Managed Care Pharmacy (AMCP) of the acceptance of their abstract, “Improving Adherence to HIV PREP via a PBM-Driven Educational Intervention” , for presentation at AMCP 2024 Conference in April.
February 23, 2024
Exploring the rising costs and demands of weight-loss medication and how to combat those costs, significantly lowering drug costs for payors and increasing access for patients who need them.
January 16, 2024
A message from Marileny Lugo, President, MC-Rx
January 16, 2024
A message from Marileny Lugo, President, MC-Rx
January 10, 2024
To decrease the burden on healthcare costs, at MC-Rx we strive to create awareness by educating our community regarding the importance of prevention.
September 28, 2023
Increased medication adherence has been linked to better clinical and financial outcomes.
More Posts
Share by: